Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Biomarker in Heart Failure: The Past, Present and Future |
Xiaojun Du | Experimental Cardiology Laboratory, Baker Heart and Diabetes Institute |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
The Role of Biomarker in the Prevention, Assessment and Management of Heart Failure |
Qian Tong | The First Bethune Hospital of Jilin University |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
New Biomarkers in Heart Failure |
Xinli Li | Jiangsu Province Hospital ( The First Affiliated Hospital with Nanjing Medical University) |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
Heart Failure without BNP Elevation |
Hua Wang | |
10:21-10:30 | 10:21-10:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
11:00-11:15 | 11:00-11:15 |
Application and Interpretation of MR Imaging in Heart Failure |
Min Liu | China-Japan Friendship Hospital, China |
11:15-11:22 | 11:15-11:22 |
Discussion |
||
11:22-11:37 | 11:22-11:37 |
Value of Contrast-Enhanced Ultrasound in Heart Failure |
Fang Wang | Beijing Hospital |
11:37-11:44 | 11:37-11:44 |
Discussion |
||
11:44-11:59 | 11:44-11:59 |
Value of Myocardial Metabolism Imaging in Heart Failure |
Wei Dong | |
11:59-12:06 | 11:59-12:06 |
Discussion |
||
12:06-12:21 | 12:06-12:21 |
Bedside Ultrasound in the Differential Diagnosis of Dyspenea |
Xin Du | Tianjin Medical University General Hospital |
12:21-12:30 | 12:21-12:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Should SGLT2 Inhibitor Be Used as A First-Line Treatment in Patients with Heart Failure: Pros |
Yihong Sun | China-Japan Friendship Hospital |
14:15-14:30 | 14:15-14:30 |
Should SGLT2 Inhibitor Be Used as A First-Line Treatment in Patients with Heart Failure: Cons |
Yong Li | Huashan Hospital Fudan University |
14:30-14:45 | 14:30-14:45 |
Discussion |
||
14:45-15:00 | 14:45-15:00 |
Classification of HF by EF Should Be Maintained: Pros |
Xiaoping Ji | Qilu Hospital of Shandong University |
15:00-15:15 | 15:00-15:15 |
Classification of HF by EF Should Be Maintained Cons |
Jinqiu Liu | |
15:15-15:30 | 15:15-15:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
16:00-16:05 | 16:00-16:05 |
Opening Speech
Changsheng Ma
Beijing Anzhen Hospital, Capital Medical University /
Jiguang Wang
Ruijin Hospital, Shanghai Jiaotong University /
Weixian Yang
|
||
16:05-16:10 | 16:05-16:10 |
Agenda and Expert Introduction
Changsheng Ma
Beijing Anzhen Hospital, Capital Medical University /
Jiguang Wang
Ruijin Hospital, Shanghai Jiaotong University /
Weixian Yang
|
||
16:10-16:30 | 16:10-16:30 |
Hotlines: Interpretation of EMPEROR-Reduced Trail |
Pingsheng Wu | Southern Medical University Nanfang Hospital |
16:30-16:35 | 16:30-16:35 |
Discussion
Yihong Sun
China-Japan Friendship Hospital
|
||
16:35-16:55 | 16:35-16:55 |
Hotlines: Interpretation of BPLTTC Trial |
Jinxiu Lin | The First Affiliated Hospital of Fujian Medical University |
16:55-17:00 | 16:55-17:00 |
Discussion
Jing Liu
Peking University People's Hospital
|
||
17:00-17:20 | 17:00-17:20 |
Hotlines: Interpretation of EXPLORER-HCM Trial |
Lei Song | |
17:20-17:25 | 17:20-17:25 |
Discussion
Yuhua Liao
Union Hospital of Tongji Medical College,Huazhong University of Science and Technology
|
||
17:25-17:30 | 17:25-17:30 |
Summary
Changsheng Ma
Beijing Anzhen Hospital, Capital Medical University /
Jiguang Wang
Ruijin Hospital, Shanghai Jiaotong University /
Weixian Yang
|